ArticleTherapeutic advances in neurological disorders2026

Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.

Vera Bril et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.